港股異動 | 啤酒股普漲 潤啤(0291.HK)、青啤(0168.HK)齊創歷史新高
格隆匯1月8日丨啤酒股普漲,潤啤(0291.HK)漲超5%領漲,盤中高見78.6港元續創歷史新高,市值超2400億港元,該股去年累漲66.4%。青啤(0168.HK)亦漲近4%創歷史新高,市值超1200億港元,該股去年累漲56.88%。花旗近日發表中資消費股報吿表示,基於六個因素(包括復甦溢價、以消費者為中心、創新、供應鏈快速回應能力、盈利復甦確定性、強現金流),挑選出包括華潤啤酒等在內的2021年中資內需股的首選。富瑞曾預期潤啤等股票將在2月底公佈的季檢中染藍,並且沒有股份被剔出成分股。同時,該行估計將有2.28億美元追入華潤啤酒。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.